IN2014MN02358A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MN02358A IN2014MN02358A IN2358MUN2014A IN2014MN02358A IN 2014MN02358 A IN2014MN02358 A IN 2014MN02358A IN 2358MUN2014 A IN2358MUN2014 A IN 2358MUN2014A IN 2014MN02358 A IN2014MN02358 A IN 2014MN02358A
- Authority
- IN
- India
- Prior art keywords
- compounds
- pharmaceutically acceptable
- treatment
- bacterial infection
- formula
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 4
- 208000035143 Bacterial infection Diseases 0.000 abstract 2
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12165882 | 2012-04-27 | ||
| PCT/EP2013/058697 WO2013160431A1 (en) | 2012-04-27 | 2013-04-26 | Antibacterial quinoline derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN02358A true IN2014MN02358A (cg-RX-API-DMAC7.html) | 2015-08-14 |
Family
ID=48325651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2358MUN2014 IN2014MN02358A (cg-RX-API-DMAC7.html) | 2012-04-27 | 2013-04-26 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9617244B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2841426B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6153603B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102110366B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN104254528B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2013254670B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2869453C (cg-RX-API-DMAC7.html) |
| DK (1) | DK2841426T3 (cg-RX-API-DMAC7.html) |
| EA (1) | EA038350B1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2607879T3 (cg-RX-API-DMAC7.html) |
| IN (1) | IN2014MN02358A (cg-RX-API-DMAC7.html) |
| MX (1) | MX358506B (cg-RX-API-DMAC7.html) |
| PL (1) | PL2841426T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT2841426T (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013160431A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2841425B1 (en) * | 2012-04-27 | 2016-03-23 | Janssen Pharmaceutica, N.V. | Antibacterial quinoline derivatives |
| WO2018048882A1 (en) | 2016-09-06 | 2018-03-15 | The Research Foundation For The State University Of New York | Positron imaging tomography imaging agent composition and method for bacterial infection |
| US20250214980A1 (en) | 2022-03-14 | 2025-07-03 | Slap Pharmaceuticals Llc | Multicyclic compounds |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2270123A1 (en) | 1996-10-28 | 1998-05-07 | Department Of The Army, U.S. Government | Compounds, compositions and methods for treating antibiotic-resistant infections |
| US6103905A (en) | 1997-06-19 | 2000-08-15 | Sepracor, Inc. | Quinoline-indole antimicrobial agents, uses and compositions related thereto |
| GB0118238D0 (en) * | 2001-07-26 | 2001-09-19 | Smithkline Beecham Plc | Medicaments |
| JP4484703B2 (ja) | 2002-07-25 | 2010-06-16 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | キノリン誘導体およびミコバクテリア抑制剤としてのそれらの使用 |
| PL1711181T3 (pl) | 2004-01-23 | 2010-02-26 | Janssen Pharmaceutica Nv | Pochodne chinoliny i ich zastosowanie jako inhibitorów mykobakteryjnych |
| US7338949B2 (en) * | 2004-01-23 | 2008-03-04 | Janssen Pharmaceutica N.V. | Mycobacterial inhibitors |
| EA011572B9 (ru) | 2004-01-29 | 2018-01-31 | Янссен Фармацевтика Н.В. | Производные хинолина для применения в качестве микобактериальных ингибиторов |
| AU2005249231B2 (en) | 2004-05-28 | 2010-11-11 | Janssen Pharmaceutica N.V. | Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases |
| WO2005123081A2 (en) | 2004-06-22 | 2005-12-29 | Janssen Pharmaceutica N.V. | (2-benzyl-4-{4-[1-(tetrahydrofuran-3-carbonyl)-pyrrolidin-3-yl]-piperazin-1-yl}-piperidin-1-yl)-(3,5-trifluoromethyl-phenyl))-methanone for the treatment of schizophrenia |
| PT1797115T (pt) | 2004-09-28 | 2017-08-29 | Janssen Pharmaceutica Nv | Domínio de ligação de atp-sintase bacteriana |
| EE05394B1 (et) | 2004-12-24 | 2011-04-15 | Janssen Pharmaceutica N.V. | Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis |
| CA2528849C (en) | 2005-06-08 | 2014-01-14 | Janssen Pharmaceutica N.V. | Quinoline derivatives as antibacterial agents |
| JO2752B1 (en) | 2005-06-28 | 2014-03-15 | شركة جانسين فارماسوتيكا ان. في | Quinoline derivatives acting as antibacterial agents |
| JO3270B1 (ar) | 2005-06-28 | 2018-09-16 | Janssen Pharmaceutica Nv | مشتقات كوينولين بصفة عوامل مضادة للبكتيريا |
| HRP20170044T1 (hr) | 2005-06-28 | 2017-03-10 | Janssen Pharmaceutica Nv | Derivati kinolina kao antibakterijska sredstva |
| JO3077B1 (ar) | 2005-07-28 | 2017-03-15 | Janssen Pharmaceutica Nv | مشتقات كوينولين مضادة للبكتيريا |
| JO2855B1 (en) | 2005-08-03 | 2015-03-15 | شركة جانسين فارماسوتيكا ان. في | Quinoline derivatives acting as antibacterial agents |
| JO2952B1 (en) | 2005-08-03 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Quinoline derivatives acting as antibacterial agents |
| JO2837B1 (en) | 2005-08-03 | 2014-09-15 | جانسن فارمسيتكا ان في | Quinoline derivatives acting as antibacterial agents |
| JO2684B1 (en) | 2006-12-06 | 2013-03-03 | جانسين فارماسوتيكا ان في | Quinoline antibacterial derivatives |
| JO2970B1 (en) | 2006-12-06 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
| JO3271B1 (ar) | 2006-12-06 | 2018-09-16 | Janssen Pharmaceutica Nv | مشتقات الكوينولين المضادة للجراثيم |
| JO2685B1 (en) | 2006-12-06 | 2013-03-03 | جانسين فارماسوتيكا ان في | Quinoline antibacterial derivatives |
| JO2683B1 (en) | 2006-12-06 | 2013-03-03 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
| JO2725B1 (en) * | 2006-12-06 | 2013-09-15 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
| CA2711912A1 (en) * | 2008-01-14 | 2009-07-23 | Jyoti Chattopadhyaya | Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivates as anti-mycobacterial agents |
| EP2841425B1 (en) * | 2012-04-27 | 2016-03-23 | Janssen Pharmaceutica, N.V. | Antibacterial quinoline derivatives |
-
2013
- 2013-04-26 MX MX2014013055A patent/MX358506B/es active IP Right Grant
- 2013-04-26 CA CA2869453A patent/CA2869453C/en active Active
- 2013-04-26 WO PCT/EP2013/058697 patent/WO2013160431A1/en not_active Ceased
- 2013-04-26 CN CN201380021822.1A patent/CN104254528B/zh active Active
- 2013-04-26 ES ES13720875.7T patent/ES2607879T3/es active Active
- 2013-04-26 IN IN2358MUN2014 patent/IN2014MN02358A/en unknown
- 2013-04-26 PT PT137208757T patent/PT2841426T/pt unknown
- 2013-04-26 US US14/391,034 patent/US9617244B2/en active Active
- 2013-04-26 PL PL13720875T patent/PL2841426T3/pl unknown
- 2013-04-26 EA EA201491971A patent/EA038350B1/ru unknown
- 2013-04-26 EP EP13720875.7A patent/EP2841426B1/en active Active
- 2013-04-26 JP JP2015507547A patent/JP6153603B2/ja active Active
- 2013-04-26 DK DK13720875.7T patent/DK2841426T3/en active
- 2013-04-26 AU AU2013254670A patent/AU2013254670B2/en not_active Ceased
- 2013-04-26 KR KR1020147030645A patent/KR102110366B1/ko not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| PT2841426T (pt) | 2016-11-23 |
| ES2607879T3 (es) | 2017-04-04 |
| KR20150013148A (ko) | 2015-02-04 |
| AU2013254670B2 (en) | 2017-03-30 |
| JP6153603B2 (ja) | 2017-06-28 |
| EA201491971A1 (ru) | 2015-02-27 |
| EA038350B1 (ru) | 2021-08-12 |
| HK1201520A1 (en) | 2015-09-04 |
| MX2014013055A (es) | 2014-12-10 |
| AU2013254670A1 (en) | 2014-10-16 |
| KR102110366B1 (ko) | 2020-05-14 |
| CN104254528A (zh) | 2014-12-31 |
| PL2841426T3 (pl) | 2017-03-31 |
| DK2841426T3 (en) | 2017-01-09 |
| EP2841426B1 (en) | 2016-09-28 |
| JP2015514795A (ja) | 2015-05-21 |
| CN104254528B (zh) | 2017-06-06 |
| CA2869453A1 (en) | 2013-10-31 |
| EP2841426A1 (en) | 2015-03-04 |
| US9617244B2 (en) | 2017-04-11 |
| CA2869453C (en) | 2021-03-02 |
| US20150051244A1 (en) | 2015-02-19 |
| WO2013160431A1 (en) | 2013-10-31 |
| MX358506B (es) | 2018-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JO3271B1 (ar) | مشتقات الكوينولين المضادة للجراثيم | |
| MY198204A (en) | Cyclic Boronic Acid Ester Derivatives And Therapeutic Uses Thereof | |
| PH12017500281B1 (en) | Pyrrolopyrimidine compounds used as tlr7 agonist | |
| UA101305C2 (ru) | Антибактериальные производные хинолина | |
| PH12014502524A1 (en) | Carboxylic acid compounds | |
| MD4736B1 (ro) | Compus policiclic de carbamoilpiridonă şi utilizarea farmaceutică a acestuia | |
| NZ710854A (en) | Quinolines derivatives as novel anticancer agents | |
| IN2014MN02364A (cg-RX-API-DMAC7.html) | ||
| JO2725B1 (en) | Quinoline antibacterial derivatives | |
| JO2970B1 (en) | Quinoline antibacterial derivatives | |
| JO2685B1 (en) | Quinoline antibacterial derivatives | |
| IN2014MN02358A (cg-RX-API-DMAC7.html) | ||
| UA101307C2 (ru) | Антибактериальные производные хинолина | |
| IN2014MN02363A (cg-RX-API-DMAC7.html) | ||
| IN2014MN02433A (cg-RX-API-DMAC7.html) |